Precision Biosensor

Precision Biosensor Interest Coverage

The Interest Coverage Ratio of Precision Biosensor (335810.KQ) as of Oct 28, 2026 is -2.84. In the previous year, Interest Coverage Ratio was -4.86 — a change of -41.54% (higher).

Interest Coverage

-2.84

YoY

-41.54%

Last updated:

Interest Coverage Ratio of Precision Biosensor is 2024 -2.84 . Interest Coverage Ratio of Precision Biosensor was 2023 -4.86 . It decreases by -41.54% higher compared to the previous year.

The Precision Biosensor Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
-4.58 KRW
Jan 1, 2018
-2.35 KRW
Jan 1, 2019
-1.18 KRW
Jan 1, 2020
-0.43 KRW
Jan 1, 2021
-12.51 KRW
Jan 1, 2022
-2.47 KRW
Jan 1, 2023
-4.86 KRW
Jan 1, 2024
-2.84 KRW
The Precision Biosensor Interest Coverage history
YEARInterest CoverageYoY
-2.84-41.54%
-4.86+96.25%
-2.47-80.22%
-12.51+2,788.82%
-0.43-63.37%
-1.18-49.62%
-2.35-48.73%
-4.58—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Precision Biosensor Stock analysis

What does Precision Biosensor do? Precision Biosensor Inc. generates revenue through the sale of portable immunoassay diagnostic devices and cartridges. The testers, which are portable devices using colorimetric and time-resolved fluorescence, are sold for on-site diagnosis of acute heart disease, metabolism, and inflammatory diseases. The cartridges, designed for gold absorption and time-resolved fluorescence analysis, are used in diagnostic equipment to check the same conditions. The company targets domestic and overseas markets including Europe, China, the Middle East, and Southeast Asia for its products. The firm's primary customers are healthcare providers and diagnostic laboratories seeking rapid, on-site testing solutions. These segments value the portability and speed of the testers, which enable immediate diagnosis without laboratory processing. The cartridges complement the testers by providing consumable components for consistent diagnostic accuracy across various medical conditions. Precision Biosensor Inc. focuses on markets where demand for point-of-care diagnostics is growing, particularly in regions with expanding healthcare infrastructure. The company's product line addresses acute heart disease, metabolism, and inflammatory diseases, aligning with global health priorities. Sales in Europe, China, the Middle East, and Southeast Asia reflect the company's strategy to serve both developed and emerging healthcare systems. Precision Biosensor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Precision Biosensor stock

Interest Coverage Ratio of Precision Biosensor is -2.84 in 2024.

Interest Coverage Ratio of Precision Biosensor changed from -4.86 to -2.84, representing a -41.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Precision Biosensor since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Precision Biosensor with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Precision Biosensor

All Key Metrics — Precision Biosensor